Pediatr Infect Dis J. 2016;35(1):81-93. MenACWY-CRM was supplied in 2 vials: 1 vial of lyophilized powder containing 10 μg of MenA oligosaccharide conjugated to CRM 197 and a second liquid ...

The vaccine used in the RV144 trial is a combination of two vaccines given in a 'prime–boost' strategy: ALVAC-HIV from Sanofi Pasteur (Swiftwater, PA, USA) and AIDSVAX from VaxGene (San ...

Accessed September 2024. 9 Sanofi Pasteur Inc. Data on File. 10 Fluzone High-Dose [Prescribing Information]. Swiftwater, PA. 11 DiazGranados, Carlos A et. al. Efficacy of High-Dose versus Standard ...

PARIS (AP) — PARIS (AP) — Sanofi (SNY) on Friday reported third-quarter earnings of $3.09 billion. The company said it had net income of $1.23 per share. Earnings, adjusted for non-recurring costs, ...

French drug major Sanofi (SNYNF, SNY) reported third quarter net income attributable to equity holders of the company of 2.82 billion ...

The French pharmaceutical company posted better-than-expected earnings and sales in the third quarter, boosted by ...

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% controlling stake in its consumer health business Opella. With the French ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the matter, an unexpected twist in one of the biggest deals in Europe this year.